Global and Region Nicotinamide Phosphoribosyltransferase Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Nicotinamide Phosphoribosyltransferase market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nicotinamide Phosphoribosyltransferasemarket, defines the market attractiveness level of Nicotinamide Phosphoribosyltransferase market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nicotinamide Phosphoribosyltransferase industry, describes the types of Nicotinamide Phosphoribosyltransferase market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nicotinamide Phosphoribosyltransferase market and the development prospects and opportunities of Nicotinamide Phosphoribosyltransferase industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nicotinamide Phosphoribosyltransferase market in Chapter 13.

    By Player:

    • Karyopharm Therapeutics, Inc

    • Calico LLC

    • Angelini Group

    • Aurigene Discovery Technologies Limited

    • FORMA Therapeutics, Inc

    • Genentech, Inc

    • OncoTartis, Inc

    By Type:

    • Hormone

    • Lipids

    • Small Molecule Compounds

    • Others

    By End-User:

    • Parkinson's Disease

    • Acute Lung Injury

    • Breast Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nicotinamide Phosphoribosyltransferase Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nicotinamide Phosphoribosyltransferase Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nicotinamide Phosphoribosyltransferase Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nicotinamide Phosphoribosyltransferase Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nicotinamide Phosphoribosyltransferase Market Analysis and Outlook to 2022

    • 7.1 Global Nicotinamide Phosphoribosyltransferase Consumption (2017-2022)

    • 7.2 United States Nicotinamide Phosphoribosyltransferase Consumption (2017-2022)

    • 7.3 Europe Nicotinamide Phosphoribosyltransferase Consumption (2017-2022)

    • 7.4 China Nicotinamide Phosphoribosyltransferase Consumption (2017-2022)

    • 7.5 Japan Nicotinamide Phosphoribosyltransferase Consumption (2017-2022)

    • 7.6 India Nicotinamide Phosphoribosyltransferase Consumption (2017-2022)

    • 7.7 South Korea Nicotinamide Phosphoribosyltransferase Consumption (2017-2022)

    8 Region and Country-wise Nicotinamide Phosphoribosyltransferase Market Analysis and Outlook to 2028

    • 8.1 Global Nicotinamide Phosphoribosyltransferase Consumption Forecast (2022-2028)

    • 8.2 United States Nicotinamide Phosphoribosyltransferase Consumption Forecast (2022-2028)

    • 8.3 Europe Nicotinamide Phosphoribosyltransferase Consumption Forecast (2022-2028)

    • 8.4 China Nicotinamide Phosphoribosyltransferase Consumption Forecast (2022-2028)

    • 8.5 Japan Nicotinamide Phosphoribosyltransferase Consumption Forecast (2022-2028)

    • 8.6 India Nicotinamide Phosphoribosyltransferase Consumption Forecast (2022-2028)

    • 8.7 South Korea Nicotinamide Phosphoribosyltransferase Consumption Forecast (2022-2028)

    9 Global Nicotinamide Phosphoribosyltransferase Market Outlook by Types and Applications to 2022

    • 9.1 Global Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lipids Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Small Molecule Compounds Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Parkinson's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Acute Lung Injury Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Nicotinamide Phosphoribosyltransferase Market Outlook by Types and Applications to 2028

    • 10.1 Global Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hormone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lipids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Small Molecule Compounds Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Acute Lung Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nicotinamide Phosphoribosyltransferase Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nicotinamide Phosphoribosyltransferase Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nicotinamide Phosphoribosyltransferase Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nicotinamide Phosphoribosyltransferase Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nicotinamide Phosphoribosyltransferase Market Competitive Analysis

    • 14.1 Karyopharm Therapeutics, Inc

      • 14.1.1 Karyopharm Therapeutics, Inc Company Details

      • 14.1.2 Karyopharm Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Karyopharm Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Product and Service

    • 14.2 Calico LLC

      • 14.2.1 Calico LLC Company Details

      • 14.2.2 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Calico LLC Nicotinamide Phosphoribosyltransferase Product and Service

    • 14.3 Angelini Group

      • 14.3.1 Angelini Group Company Details

      • 14.3.2 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Angelini Group Nicotinamide Phosphoribosyltransferase Product and Service

    • 14.4 Aurigene Discovery Technologies Limited

      • 14.4.1 Aurigene Discovery Technologies Limited Company Details

      • 14.4.2 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product and Service

    • 14.5 FORMA Therapeutics, Inc

      • 14.5.1 FORMA Therapeutics, Inc Company Details

      • 14.5.2 FORMA Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 FORMA Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Product and Service

    • 14.6 Genentech, Inc

      • 14.6.1 Genentech, Inc Company Details

      • 14.6.2 Genentech, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genentech, Inc Nicotinamide Phosphoribosyltransferase Product and Service

    • 14.7 OncoTartis, Inc

      • 14.7.1 OncoTartis, Inc Company Details

      • 14.7.2 OncoTartis, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 OncoTartis, Inc Nicotinamide Phosphoribosyltransferase Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nicotinamide Phosphoribosyltransferase

    • Figure Nicotinamide Phosphoribosyltransferase Picture

    • Table Global Nicotinamide Phosphoribosyltransferase Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nicotinamide Phosphoribosyltransferase Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nicotinamide Phosphoribosyltransferase Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nicotinamide Phosphoribosyltransferase Consumption by Country (2017-2022)

    • Figure United States Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate (2017-2022)

    • Table Europe Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate (2017-2022)

    • Figure China Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate (2017-2022)

    • Figure Japan Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate (2017-2022)

    • Figure India Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nicotinamide Phosphoribosyltransferase Consumption and Growth Rate (2017-2022)

    • Figure Global Nicotinamide Phosphoribosyltransferase Consumption Forecast by Country (2022-2028)

    • Figure United States Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nicotinamide Phosphoribosyltransferase Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Lipids Consumption and Growth Rate (2017-2022)

    • Figure Global Small Molecule Compounds Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Lung Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lipids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small Molecule Compounds Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Lung Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nicotinamide Phosphoribosyltransferase Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nicotinamide Phosphoribosyltransferase Export by Region (Top 5 Countries) (2017-2028)

    • Table Karyopharm Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Karyopharm Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

    • Table Karyopharm Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Product and Service

    • Table Calico LLC (Foundation Year, Company Profile and etc.)

    • Table Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

    • Table Calico LLC Nicotinamide Phosphoribosyltransferase Product and Service

    • Table Angelini Group (Foundation Year, Company Profile and etc.)

    • Table Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

    • Table Angelini Group Nicotinamide Phosphoribosyltransferase Product and Service

    • Table Aurigene Discovery Technologies Limited (Foundation Year, Company Profile and etc.)

    • Table Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product and Service

    • Table FORMA Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table FORMA Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

    • Table FORMA Therapeutics, Inc Nicotinamide Phosphoribosyltransferase Product and Service

    • Table Genentech, Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech, Inc Nicotinamide Phosphoribosyltransferase Product and Service

    • Table OncoTartis, Inc (Foundation Year, Company Profile and etc.)

    • Table OncoTartis, Inc Nicotinamide Phosphoribosyltransferase Sales, Price, Value and Gross Profit (2017-2022)

    • Table OncoTartis, Inc Nicotinamide Phosphoribosyltransferase Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.